REGISTERED
on 06 Dec 2022
Last Applicant/ Owned by
10260 Bubb Road
Cupertino
CA
95014
Serial Number
90000195 filed on 13th Jun 2020
Registration Number
6918808 registered on 06th Dec 2022
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
OMREYSO
pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, diseases and disorders of the endocrine system, inflammatory diseases and disorders, acute organ injury, epigenetic diseases and disorders, and DNA methyltransferase (DNMT)-associated diseases and disorders
Classification Information
Class [005]
Pharmaceutical Products
pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, diseases and disorders of the endocrine system, inflammatory diseases and disorders, acute organ injury, epigenetic diseases and disorders, and DNA methyltransferase (DNMT)-associated diseases and disorders
First Use Date in General
12th Oct 2022
First Use Date in Commerce
12th Oct 2022
Mark Details
Serial Number
No 90000195
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 06th Dec 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 06th Dec 2022 | REGISTERED-PRINCIPAL REGISTER |
| 03rd Nov 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 02th Nov 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 01st Nov 2022 | STATEMENT OF USE PROCESSING COMPLETE |
| 31st Oct 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 13th Oct 2022 | USE AMENDMENT FILED |
| 13th Oct 2022 | TEAS STATEMENT OF USE RECEIVED |
| 14th Jun 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 12th Jun 2022 | SOU EXTENSION 2 GRANTED |